Track Poly Medicure Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -1.49 %
Low
1,682.3
High
1,858.0
1 Month returns: 2.15 %
Low
1,680.9
High
1,913.7
1 Year returns: -14.27 %
Low
1,182.0
High
2,109.9
3 Year CAGR: 7.63 %
Low
1,182.0
High
3,357.8
5 Year CAGR: 11.97 %
Low
651.1
High
3,357.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Poly Medicure Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Poly Medicure Ltd. Shareholding Pattern
Quarterly breakdown of Poly Medicure Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Poly Medicure Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Poly Medicure Ltd.?
The current share price of Poly Medicure Ltd. is ₹ 1,730.20 as of 8 Sep 2026.
What is the market capitalisation of Poly Medicure Ltd.?
The market capitalisation of Poly Medicure Ltd. stands at ₹ 17,537.50 Cr.
What is the PE ratio of Poly Medicure Ltd.?
The Price-to-Earnings (PE) ratio of Poly Medicure Ltd. is 54.44 as of the latest trailing twelve months data.
What is the ROE and ROCE of Poly Medicure Ltd.?
Poly Medicure Ltd. has a Return on Equity (ROE) of 10.96% and a Return on Capital Employed (ROCE) of 10.13% as per the latest financial reports.
What is the 52-week high and low of Poly Medicure Ltd.?
The 52-week high of Poly Medicure Ltd. is - and the 52-week low is -.
What is the dividend yield of Poly Medicure Ltd.?
The dividend yield of Poly Medicure Ltd. is 0.20% based on the current market price.
What is the FII and DII holding in Poly Medicure Ltd.?
Foreign Institutional Investors (FII) hold 5.56%, Domestic Institutional Investors (DII) hold 12.60% and retail/public investors hold 13.21% of Poly Medicure Ltd. shares.
What sector does Poly Medicure Ltd. belong to?
Poly Medicure Ltd. operates in the Healthcare sector. 60% of analysts have a Buy or Strong Buy rating on Poly Medicure Ltd. with a consensus target price of ₹ 1,920.00, implying 10.97% upside from current levels.
What is the beta of Poly Medicure Ltd.?
The beta of Poly Medicure Ltd. is 0.86, indicating its price volatility relative to the broader market. Over the past 1 year, Poly Medicure Ltd. has delivered an absolute return of -16.73%.
What is the RSI of Poly Medicure Ltd.?
The 14-day Relative Strength Index (RSI) of Poly Medicure Ltd. is 49.65, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Poly Medicure Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Analysts have been raising forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has increased by 1.5% in the last 3 months, indicating earnings momentum
What is Earnings upgrade (3M)?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.11 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.04 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 5 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 54.44 indicates that the stock is expensive on a standalone basis and is at a 67.56% premium to industry median P/E
What is P/E Ratio?
Median: 32.49
Value 54.44
7.04156.81
Moderate ROE but declining trend
The company reported moderate ROE of 10.96% for 12-month ended 30 Jun 2026 but ROE declined by -500 bps from 1 year ago
What is ROE (FY)?
Moderate revenue growth but lower than median growth of industry
The company delivered moderate revenue growth of 12.56% for 12-month ended 30 Jun 2026 but the growth was 3.38 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 15.94
Value 12.56
6.729.95
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -6.93% for 12-month ended 30 Jun 2026 and the growth was 33.71 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.2%
What is Dividend yield?
Neutral
High operating margin but declining trend
The company reported strong operating margin of 17.43% for 12-month ended 30 Jun 2026 but operating margin declined by -442 bps from 1 year ago
What is Operating profit margin?
Company's earnings are of moderate quality
Earnings quality score of 51.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
51.8 / 100
No red flags found!
No significant red flags found in the stock.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
History of Poly Medicure Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 3.50/share
Record date: 29th Aug 2026Ex-date: 28th Aug 2026
Announced on: 25th May 2026
Dividend₹ 3.50/share
Record date: 18th Sep 2025Ex-date: 18th Sep 2025
Announced on: 7th May 2025
Dividend₹ 3/share
Record date: 19th Sep 2024Ex-date: 19th Sep 2024
Announced on: 17th May 2024
Dividend₹ 3/share
Record date: 21st Sep 2023Ex-date: 21st Sep 2023
Announced on: 9th May 2023
Dividend₹ 2.50/share
Record date: 19th Sep 2022Ex-date: 16th Sep 2022
Announced on: 24th May 2022
1,730.2029.1 (1.71%)
-14.27% in past 1 year
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
48.76
48.76
48.76
48.77
44.88
44.77
44.77
44.76
44.66
53.34
53.33
53.33
53.31
53.31
53.16
53.16
53.15
66.03
62.56
62.44
62.44
62.44
62.42
62.42
62.42
62.42
Indian Promoter
48.50
48.50
48.51
48.51
44.64
44.54
44.54
44.53
44.42
53.10
53.33
53.09
53.08
53.08
52.94
52.94
52.93
65.81
62.35
62.23
62.23
62.23
62.21
62.21
62.21
62.21
Foreign Promoter
0.26
0.26
0.26
0.26
0.24
0.24
0.24
0.24
0.24
0.24
-
0.24
0.24
0.24
0.22
0.22
0.22
0.22
0.20
0.20
0.20
0.20
0.20
0.20
0.20
0.20
Institutions
3.08
2.60
3.11
4.01
15.12
15.71
16.55
17.12
18.40
18.84
19.66
19.71
19.88
19.86
19.64
19.55
19.60
19.26
24.20
23.99
23.42
23.13
23.31
23.24
21.50
21.65
Mutual Funds / UTI
-
0.01
0.01
0.02
1.21
1.96
2.39
2.58
2.87
2.92
3.03
3.01
3.02
3.27
3.95
4.18
4.99
6.29
7.35
7.17
7.16
7.34
8.04
8.14
8.84
9.61
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.70
0.73
0.34
0.27
0.31
0.18
0.18
0.18
0.45
0.78
0.99
1.11
2.01
2.31
3.06
2.44
2.77
2.70
2.83
3.09
3.34
2.99
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
2.90
2.36
2.86
3.75
12.61
12.82
13.68
14.13
15.07
15.59
16.27
16.33
16.21
15.61
14.49
14.10
12.37
9.91
11.86
12.31
11.44
11.41
9.77
9.40
5.92
5.56
Other Institutions
0.18
0.23
0.24
0.25
0.60
0.20
0.14
0.14
0.15
0.15
0.18
0.19
0.20
0.20
0.21
0.17
0.21
0.74
1.94
2.07
2.05
1.68
2.66
2.61
3.42
3.48
Non-Institution
48.16
48.64
48.13
47.22
40.00
39.52
38.68
38.11
36.94
27.82
27.02
26.96
26.80
26.83
27.20
27.29
27.26
14.72
13.24
13.57
14.15
14.44
14.27
14.34
16.08
15.94
Bodies Corporate
-
-
-
-
-
-
-
-
-
-
15.02
15.01
14.91
14.94
15.06
15.14
15.15
2.57
2.37
2.25
2.24
2.24
2.22
2.23
2.51
2.73
Others (incl. Retail)
No. of shareholders
48.16
8,529
48.64
10,918
48.13
16,478
47.22
18,081
40.00
21,461
39.52
35,829
38.68
33,578
38.11
35,065
36.94
33,727
27.82
33,190
12.00
33,510
11.95
31,308
11.89
34,673
11.89
35,444
12.14
33,843
12.15
35,229
12.11
35,927
12.15
36,060
10.87
37,624
11.32
59,706
11.91
64,568
12.20
70,151
12.05
63,714
12.11
67,048
13.57
72,591
13.21
72,596
Company Profile
Overview of Poly Medicure Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company o...
Key personnel
Shri. Naresh Vijayvargiya
Chief Financial Officer
Shri. Avinash Chandra
Compliance Officer, Company Secretary
Mr. Devendra Raj MehtaD
Non-Executive and Non-Independent Chairman of the Board